| Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population … MR Moore, R Link-Gelles, W Schaffner, R Lynfield, C Lexau, NM Bennett, ... The Lancet Infectious Diseases 15 (3), 301-309, 2015 | 833 | 2015 |
| Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak—United States, December 31, 2019–February 4, 2020 A Patel MMWR. Morbidity and mortality weekly report 69, 2020 | 537 | 2020 |
| Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites DR Feikin, EW Kagucia, JD Loo, R Link-Gelles, MA Puhan, T Cherian, ... PLoS medicine 10 (9), e1001517, 2013 | 524 | 2013 |
| Waning 2-dose and 3-dose effectiveness of mRNA vaccines against COVID-19–associated emergency department and urgent care encounters and hospitalizations among adults during … JM Ferdinands MMWR. Morbidity and mortality weekly report 71, 2022 | 502 | 2022 |
| Effectiveness of a third dose of mRNA vaccines against COVID-19–associated emergency department and urgent care encounters and hospitalizations among adults during periods of … MG Thompson MMWR. Morbidity and mortality weekly report 71, 2022 | 466 | 2022 |
| Characteristics associated with hospitalization among patients with COVID-19—Metropolitan Atlanta, Georgia, March–April 2020 ME Killerby MMWR. Morbidity and mortality weekly report 69, 2020 | 432 | 2020 |
| Effectiveness of Pfizer-BioNTech and Moderna vaccines in preventing SARS-CoV-2 infection among nursing home residents before and during widespread circulation of the SARS-CoV-2 … S Nanduri MMWR. Morbidity and mortality weekly report 70, 2021 | 363 | 2021 |
| Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States Nature medicine 26 (6), 861-868, 2020 | 353 | 2020 |
| National update on measles cases and outbreaks—United States, January 1–October 1, 2019 M Patel MMWR. Morbidity and Mortality Weekly Report 68, 2019 | 227 | 2019 |
| Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease in children in the USA: a matched case-control study MR Moore, R Link-Gelles, W Schaffner, R Lynfield, C Holtzman, ... The Lancet Respiratory Medicine 4 (5), 399-406, 2016 | 214 | 2016 |
| Recommendations of the Advisory Committee on Immunization Practices for use of a hepatitis B vaccine with a novel adjuvant S Schillie MMWR. Morbidity and mortality weekly report 67, 2018 | 203 | 2018 |
| Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA vaccination in preventing COVID-19–associated emergency department and urgent care encounters and hospitalizations among … NP Klein MMWR. Morbidity and mortality weekly report 71, 2022 | 195 | 2022 |
| Effectiveness of bivalent mRNA vaccines in preventing symptomatic SARS-CoV-2 infection—increasing community access to testing program, United States, September–November 2022 R Link-Gelles MMWR. Morbidity and Mortality Weekly Report 71, 2022 | 185 | 2022 |
| Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control study JM Ferdinands, S Rao, BE Dixon, PK Mitchell, MB DeSilva, SA Irving, ... Bmj 379, 2022 | 180 | 2022 |
| Public health response to a case of paralytic poliomyelitis in an unvaccinated person and detection of poliovirus in wastewater—New York, June–August 2022 R Link-Gelles MMWR. Morbidity and mortality weekly report 71, 2022 | 158 | 2022 |
| Early estimates of bivalent mRNA vaccine effectiveness in preventing COVID-19–associated emergency department or urgent care encounters and hospitalizations among … MW Tenforde MMWR. Morbidity and mortality weekly report 71, 2022 | 153 | 2022 |
| Infection control assessment of ambulatory surgical centers MK Schaefer, M Jhung, M Dahl, S Schillie, C Simpson, E Llata, ... Jama 303 (22), 2273-2279, 2010 | 152 | 2010 |
| Association of prior BNT162b2 COVID-19 vaccination with symptomatic SARS-CoV-2 infection in children and adolescents during omicron predominance KE Fleming-Dutra, A Britton, N Shang, G Derado, R Link-Gelles, ... Jama 327 (22), 2210-2219, 2022 | 151 | 2022 |
| Pneumococcal genome sequencing tracks a vaccine escape variant formed through a multi-fragment recombination event T Golubchik, AB Brueggemann, T Street, RE Gertz Jr, CCA Spencer, T Ho, ... Nature genetics 44 (3), 352-355, 2012 | 141 | 2012 |
| Interim recommendations from the Advisory Committee on Immunization Practices for the use of bivalent booster doses of COVID-19 vaccines—United States, October 2022 HG Rosenblum MMWR. Morbidity and mortality weekly report 71, 2022 | 133 | 2022 |
Amanda PayneVerified email at cdc.gov
Amanda PayneVerified email at cdc.gov